Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

SZSE
9989
Stock
Yield per half year: 0%
Dividend yield: 2.69%
Sector: Healthcare

Reporting Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Capitalization

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Капитализация, млрд ¥
16.82
Выручка, млрд ¥
6.55
Чистая прибыль, млрд ¥
0.5587
EV, млрд ¥
20.33
EBITDA, млрд ¥
1.06


Balance sheet

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Наличность, млрд ¥
3.08
Долг, млрд ¥
6.32


Share

IFRS
Reporting Annual
LTM 5 year average CAGR 5
EPS 0.42


Efficiency

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 4.5 17.91
ROA, % 2.47 8.30
ROS, % 8.53 8.53 8.53 8.53 23.77 8.53 0.00
ROCE, % 0 0 0.00
Ebit margin, % 0 0
Рентаб EBITDA, % 16.18 16.18 28.48 16.18 0.00
Чистая рентаб, % 8.53 23.79
Operation Margin, % 0 0 0 0 0.00


Coefficients

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
10.12 33.38
P/BV
0.46 5.66
P/S
0.86 9.95
P/FCF
0 0 0 0 0.00
E/P
0.0332 0.0332 0.0332 0.0332 0.04 0.0332 0.00
EV/EBIT
0 0 0
EV/EBITDA
23.33 25.59
EV/S
3.1 3.1 3.1 3.1 9.50 3.10 0.00
EV/FCF
0 0 0 0.00
Debt/EBITDA
5.96 5.96 5.96 5.96 0.59 5.96 0.00
Netdebt/Ebitda
0 0 0 0 0.00
Debt/Ratio
0 0 0 0 0.00
Debt/Equity
0 0 0 0 0.00
Debt/Net Income
11.31 11.31 11.31 11.31 0.75 11.31 0.00
PEG
0 0
Бета
0 0 0 0 0.00
Индекс Альтмана
0 0 0 0 0.00


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0.11
Див доход, ао, %
2.69 1.17
Дивиденды / прибыль, %
9.22 29.29


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
2 366 2 366 0.00